Nyxoah (NYXH) Depreciation & Amortization (CF) (2025 - 2026)

Nyxoah's quarterly Depreciation & Amortization (CF) came in at $808985.2 in Q1 2026, up 43.22% year-on-year from $564861.9 in Q1 2025, and up 43.22% quarter-over-quarter from $564861.9 in Q1 2025.

Nyxoah has reported Depreciation & Amortization (CF) for 2 years, with the latest figure at $808985.2 in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 43.22% year-over-year to $808985.2; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 143.22% YoY), and the FY2025 full-year result was $2.6 million, up 40.14% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $808985.2, up from $564861.9 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $808985.2 in Q1 2026, with the low at $564861.9 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 178.90 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 563.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 58.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 44.60 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 135.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 95.50 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 56.55 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 237.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 64.31 Mn
10 Nyxoah 1,248.49 1,248.49 4.26 Mn 808,985.24

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 808,985.24
Mar 31, 2026 808,985.24
Mar 31, 2025 564,861.94
Mar 31, 2025 564,861.94